Regulation (EU) No 658/2014 of the European Parliament and of the Council of 15 May 2014 on fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use Text with EEA relevance
Basic information
Dates Date of document:
  • May 15, 2014
Date of publication:
  • June 27, 2014
Date of effect:
  • July 17, 2014
    • Entry into force - Date pub. +20 See Art 18
Date of end of validity:
Modified by
Modified by:
All documents based on this document:
Repealed by:
Modifies
Affected by case
Legal basis
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE XIV - PUBLIC HEALTH Article 168 (ex Article 152 TEC)
  • Consolidated version of the Treaty on the Functioning of the European Union PART SIX - INSTITUTIONAL AND FINANCIAL PROVISIONS TITLE I - INSTITUTIONAL PROVISIONS Chapter 2 - Legal acts of the Union, adoption procedures and other provisions Section 2 - Procedures for the adoption of acts and other provisions Article 294 (ex Article 251 TEC)
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE VII - COMMON RULES ON COMPETITION, TAXATION AND APPROXIMATION OF LAWS Chapter 3 - Approximation of laws Article 114 (ex Article 95 TEC)
EuroVoc Vocabulary
  • Drug surveillance
  • Medicinal product
  • Proprietary medicinal products
  • Revenue
  • Health control
  • Market approval
  • Internal market - Principles
  • Quasi-fiscal charge
  • European Medicines Agency